PMFA
CRDF icon

Plante Moran Financial Advisors’s Cardiff Oncology CRDF Stock Holding History

Plante Moran Financial Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-148
Closed -$8K – 882
2017
Q3 		$8K Buy
+148
New +$9.23K ﹤0.01% 572

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $117M AUM 28.12% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Plante Moran Financial Advisors's CRDF Position: Q4 2017 in Review

Plante Moran Financial Advisors sold out of Cardiff Oncology (CRDF) in Q4 2017, closing a stake of 148 shares — an estimated $8K sold.

Plante Moran Financial Advisors first reported a position in CRDF in Q3 2017 and held it in 1 quarter. The position peaked at $8K in Q3 2017. 38 funds tracked by Wall St. Rank hold CRDF as of Q4 2017.

  • Plante Moran Financial Advisors reported no remaining Cardiff Oncology position as of Q4 2017 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 148 Cardiff Oncology shares in Q4 2017, an estimated $8K.
  • Plante Moran Financial Advisors first reported a position in Cardiff Oncology in Q3 2017 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Cardiff Oncology position peaked at $8K in Q3 2017.
  • 38 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2017.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.